Targeted delivery of EV peptide to tumor cell cytoplasm using lipid coated calcium carbonate nanoparticles

Cancer Letters

Volumn 334, Issue 2, 2013, Pages 311-318

  Kim, Sang Kyoon ^a   Foote, Michael B ^a   Huang, Leaf ^a  

^a University of North Carolina   (United States)

Author keywords

Apoptosis; Calcium carbonate; Nanoparticle; Therapeutic peptide

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CALCIUM; CALCIUM CARBONATE; CELL PENETRATING PEPTIDE; CREATINE; EV PEPTIDE; LIPID; MACROGOL 2000; NANOPARTICLE; NITROGEN; PHOSPHATIDYLETHANOLAMINE; SIGMA OPIATE RECEPTOR; SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MOLECULARLY TARGETED THERAPY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BIOMIMETIC MATERIALS; CALCIUM CARBONATE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CYTOPLASM; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; HUMANS; HYDRAZINES; HYDROGEN-ION CONCENTRATION; LIPIDS; LUNG NEOPLASMS; MICE; MICE, NUDE; NANOPARTICLES; PEPTIDES; RANDOM ALLOCATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ALEXA;

EID: 84878225830     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.07.011     Document Type: Article

References (28)

1. Kumar S., Blake S.M., Emery J.G. Intracellular signaling pathways as a target for the treatment of rheumatoid arthritis. Curr. Opin. Pharmacol. 2001, 1:307-313.
2. Matter A. Tumor angiogenesis as a therapeutic target. Drug Discov. Today 2001, 6:1005-1024.
3. Lark M.W., Morrison K.E. Musculoskeletal diseases: novel targets for therapeutic intervention. Curr. Opin. Pharmacol. 2002, 2:287-290.
4. Bidwell G.L., Raucher D. Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades. Exp. Opin. Drug Deliv. 2009, 6(10):1033-1047.
5. Kim S.K., Huang L. Nanoparticle delivery of a peptide targeting EGFR signaling. J. Control. Release 2012, 157(2):279-286.
6. El-Andaloussi S., Holm T., Langel ü. Cell-penetrating peptides: mechanisms and applications. Curr. Pharmaceut. Des. 2005, 11:3597-3611.
7. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 2001, 276:5836-5840.
8. Tseng Y.L., Liu J.J., Hong R.L. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. Mol. Pharmacol. 2002, 62:864-872.
9. Bitler B.G., Schroeder J.A. Anti-cancer therapies that utilize cell penetrating peptides. Recent Pat. Anticancer Drug Discov. 2010, 5(2):99-108.
10. Cardozo A.K., Buchillier V., Mathieu M., Chen J., Ortis F., Ladrière L., Allaman-Pillet N., Poirot O., Kellenberger S., Beckmann J.S., Eizirik D.L., Bonny C., Maurer F. Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. Biochim. Biophys. Acta (BBA) - Biomembr. 2007, 1769(9):2222-2234.
11. Foerg C., Merkle H.P. On the biomedical promise of cell penetrating peptides: limits versus prospects. J. Pharm. Sci. 2008, 97(1):144-162.
12. Said Hassane F., Saleh A.F., Abes R., Gait M.J., Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol. Life Sci. 2010, 67(5):715-726.
13. S. Trabulo, A.L. Cardoso, M. Mano, M.C. Pedroso De Lima, Cell penetrating peptides - mechanisms of cellular uptake and generation of delivery system, Pharmaceuticals 3(4) (2010) 961-993.
14. Hobbs K., Monsky W., Yuan F., Roberts W., Griffith L., Torchilin V.P., Jain R. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 1998, 95:4607-4612.
15. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995, 55:3752-3756.
16. K. Cho, X. Wang, S. Nie, Z. (Georgia) Chen, D.M. Shin, Therapeutic nanoparticles for drug delivery in cancer, Clin. Cancer Res. 14 (2008) 1310.
17. Praetorius N.P., Mandal T.K. Engineered nanoparticles in cancer therapy. Recent Pat. Drug Deliv. Formul. 2007, 1(1):37-51.
18. Li S.D., Huang L. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. Biochim. Biophys. Acta 2009, 1788(10):2259-2266.
19. Guo S., Huang L. Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy. J. Nanomater. 2011, 2011:12.
20. Kim S.K., Foote M., Huang L. The targeted intracellular delivery of cytochrome c protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials 2012, 33(15).
21. Li J., Chen Y.C., Tseng Y.C., Huang L. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. J. Control. Release 2010, 142(3):416-421.
22. Li J., Yang Y., Huang L. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. J. Control. Release 2012, 158(1):108-114.
23. Steiner P., Joynes C., Bassi R., Wang S., Tonra J.R., Hadari Y.R., Hicklin D.J. Tumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptor. Clin. Cancer Res. 2007, 13:1540.
24. Li S., Chen Y.C., Hackett M.J., Huang L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol. Ther. 2008, 16(1):163-169.
25. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 1995, 92(16):7297-7301.
26. Aydar E., Palmer C.P., Djamgoz B.A. Sigma receptors and cancer: possible involvements of ion channels. Cancer Res. 2004, 64:5029-5035.
27. John C.S., Varma V.M., McAfee J.G., Moody T.W. Sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci. 1995, 56:2385-2392.
28. B.J. Vilner, C.S. John, W.D. Bowen, Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines, Cancer Res. 55 (1995) 408-413.